Compare OBK & INSP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | OBK | INSP |
|---|---|---|
| Founded | 1912 | 2007 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Major Banks | Medical/Dental Instruments |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.4B | 1.6B |
| IPO Year | 2018 | 2018 |
| Metric | OBK | INSP |
|---|---|---|
| Price | $45.31 | $40.17 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 6 | 16 |
| Target Price | $46.67 | ★ $94.00 |
| AVG Volume (30 Days) | 158.4K | ★ 1.0M |
| Earning Date | 04-22-2026 | 05-04-2026 |
| Dividend Yield | ★ 2.13% | N/A |
| EPS Growth | N/A | ★ 179.43 |
| EPS | ★ 0.89 | N/A |
| Revenue | N/A | ★ $82,050,000.00 |
| Revenue This Year | $26.43 | $8.02 |
| Revenue Next Year | $5.79 | $8.11 |
| P/E Ratio | $51.83 | ★ N/A |
| Revenue Growth | N/A | ★ 62.18 |
| 52 Week Low | $32.13 | $41.52 |
| 52 Week High | $48.12 | $152.36 |
| Indicator | OBK | INSP |
|---|---|---|
| Relative Strength Index (RSI) | 47.76 | 27.58 |
| Support Level | $42.75 | N/A |
| Resistance Level | $46.02 | $59.40 |
| Average True Range (ATR) | 1.13 | 2.74 |
| MACD | -0.31 | -1.04 |
| Stochastic Oscillator | 8.17 | 3.06 |
Origin Bancorp Inc is a financial holding company that provides personalized, relationship banking to businesses, municipalities, and personal clients in the communities it serves. The company offers a broad range of financial services and operates more than 56 locations in Dallas/Fort Worth, East Texas, Houston, North Louisiana, Mississippi, South Alabama, and the Florida Panhandle. It also provides insurance agency products and services through its wholly owned insurance agency subsidiary. The company operates in one business segment, community banking, and is mainly engaged in attracting deposits from individuals and businesses and using these deposits and borrowed funds to originate commercial, residential mortgage, construction, and consumer loans.
Inspire Medical Systems Inc operates as a medical technology company. It focuses on the development and commercialization of minimally invasive solutions for patients with obstructive sleep apnea (OSA). It offers Inspire system, a neurostimulation technology that provides a safe and effective treatment for moderate to severe obstructive sleep apnea. The firm has operating footprints in the United States and All other countries wherein, it generates a majority of its revenue from the United States. Its segment revenues are derived from the sales of its product, the Inspire system, to hospitals and ambulatory surgery centers in the U.S. and in selected countries in Europe and the Asia Pacific region.